208 related articles for article (PubMed ID: 3717305)
1. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study.
Eusebi V; Millis RR; Cattani MG; Bussolati G; Azzopardi JG
Am J Pathol; 1986 Jun; 123(3):532-41. PubMed ID: 3717305
[TBL] [Abstract][Full Text] [Related]
2. [Apocrine carcinoma of the breast--a morphologic comparison of the apocrine sweat glands and the apocrine metaplastic epithelia in mastopathy].
Tsubura A; Uemura Y; Inui T; Izumi H; Morii S
Gan No Rinsho; 1988 Jun; 34(7):901-7. PubMed ID: 3398262
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
[TBL] [Abstract][Full Text] [Related]
4. [Ten cases of an apocrine carcinoma of the breast and a review of cases in the Japanese literature].
Aoyagi H; Ishida T; Yamada I; Kurebayashi J; Kurosumi M; Yokoe T; Ogawa T; Kawai T; Izuo M
Gan No Rinsho; 1990 May; 36(6):681-90. PubMed ID: 2190018
[TBL] [Abstract][Full Text] [Related]
5. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
Mazoujian G; Pinkus GS; Davis S; Haagensen DE
Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
[TBL] [Abstract][Full Text] [Related]
7. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
9. Apocrine gland adenoma and adenocarcinoma of the axilla.
Warkel RL; Helwig EB
Arch Dermatol; 1978 Feb; 114(2):198-203. PubMed ID: 629545
[TBL] [Abstract][Full Text] [Related]
10. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
Kaya H; Bozkurt SU; Erbarut I; Djamgoz MB
Pathol Res Pract; 2008; 204(6):367-71. PubMed ID: 18342452
[TBL] [Abstract][Full Text] [Related]
11. [Tubular apocrine adenoma. Description of 4 cases].
Barnadas MA; Moreno A; Pujol R; Freeman RG; De Moragas JM
Med Cutan Ibero Lat Am; 1990; 18(1):35-9. PubMed ID: 2214926
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical and ultrastructural diagnosis of a rare mixed apocrine-medullary carcinoma of the breast in a fine needle aspirate.
Gupta RK; Wakefield J; Naran S; Dowle CC
Acta Cytol; 1989; 33(1):104-8. PubMed ID: 2644742
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation.
Misago N; Narisawa Y
J Dermatol; 2006 Jan; 33(1):2-9. PubMed ID: 16469077
[TBL] [Abstract][Full Text] [Related]
14. Apocrine carcinoma, adenopathies, and raised TAG-72 serum tumor marker.
Santos-Juanes J; Bernaldo de Quirós JF; Galache Osuna C; Sánchez del Río J; Allende MT; Folgueras MV; Soto de Delás J
Dermatol Surg; 2004 Apr; 30(4 Pt 1):566-9. PubMed ID: 15056154
[TBL] [Abstract][Full Text] [Related]
15. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
[TBL] [Abstract][Full Text] [Related]
16. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
[TBL] [Abstract][Full Text] [Related]
17. Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study.
Paties C; Taccagni GL; Papotti M; Valente G; Zangrandi A; Aloi F
Cancer; 1993 Jan; 71(2):375-81. PubMed ID: 7678545
[TBL] [Abstract][Full Text] [Related]
18. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
Shim HS; Jung WH; Kim H; Park K; Cho NH
APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
[TBL] [Abstract][Full Text] [Related]
19. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature.
Miyamoto T; Hagari Y; Inoue S; Watanabe T; Yoshino T
J Clin Pathol; 2005 Jul; 58(7):757-61. PubMed ID: 15976347
[TBL] [Abstract][Full Text] [Related]
20. Axillary apocrine carcinoma associated with apocrine adenoma and apocrine gland hyperplasia.
Bujas T; Pavić I; Lenicek T; Mijić A; Kruslin B; Tomas D
Acta Dermatovenerol Croat; 2007; 15(3):148-51. PubMed ID: 17868540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
